Startup tech helps Parkinson’s disease patients track symptoms
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Coverage of Sarepta Duchenne drug may be halted by N.Y. state Medicaid
In a setback for Sarepta Therapeutics, a New York panel has voted unanimously to recommend the state Medicaid…
Parents flock to Tylenol alternatives amid Trump autism claims
When President Trump warned that pregnant women and children should avoid taking Tylenol, the wellness industry was ready…
Trump Medicare rule delays fix for drug price negotiation loophole
WASHINGTON — The Trump administration is delaying a proposal to crack down on a loophole that allows drugmakers…
UnitedHealth names Duke’s Michael Pencina chief AI scientist
Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and…
A Q&A with the AHA’s Lisa Suennen| STAT
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach…
Tylenol’s 70-year history: From kids’ drug to political controversy
Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT…
Acadia Pharmaceuticals drug for rare genetic condition fails late-stage study
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
FDA cracks down on prescription drug ads but lacks staff
WASHINGTON – In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health…
Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer look
Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture…